Codexis (CDXS) 10-Q 2015 Q1 Quarterly report

AMENDMENT NO. 2 TO SITAGLIPTIN SUPPLY AGREEMENT

AMENDMENT NO. 2 TO SITAGLIPTIN CATALYST SUPPLY AGREEMENT effective as ofFebruary 25, 2015 (this “Amendment”) by and between Codexis, INC, (the “Vendor”), a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, CA 94063 (“CODEXIS”) and MERCK SHARP and DOHME (the “Company”), having a place of business at One Merck Drive, Whitehouse Station, NJ 08889-0100. (“MERCK”)

W I T N E S S E T H:

WHEREAS, the parties are party to that certain SITAGLIPTIN CATALYST SUPPLY AGREEMENT dated as of February 1^st 2012, as amended as of October 1, 2013, as the same may have been amended to the effective date of this Amendment (as so amended, the “Agreement”); and

WHEREAS, the parties desire to amend the Agreement to modify the payment terms of the Agreement as more fully set forth below;

NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

1. Additions and changes made to the Agreement in this Amendment:

1.01 Annual License Fees owed by MERCK pursuant to section 4.1.1 of the Agreement shall be paid to Codexis no later than 90 days after the receipt of the invoice and in any event no later than February 28 of each calendar year.

1.02 These amended Annual License Fee payment terms will be effective on February 28, 2016.

1. Miscellaneous

2.01 Effect of Amendment; Joinder. Except as expressly changed by this Amendment, the Agreement shall remain in full force and effect in accordance with its stated terms. The Agreement and the Schedules and Exhibits thereto, as amended by this Amendment and all preceding amendments, set forth the entire understanding of the parties with respect to the subject matter thereof. There are no agreements, restrictions, promises, warranties, covenants or undertakings other than those expressly set forth or referred to therein. The Agreement and the Schedules and Exhibits thereto, as amended by this Amendment, supersede all prior agreements and undertakings between the parties with respect to such subject matter.

2.02 Counterparts. This Amendment may be executed by the parties in separate counterparts, each of which when so executed and delivered is deemed an original. All such counterparts together constitute but one and the same instrument.

2.03 Definitions. All capitalized terms used but not defined in this Amendment shall have the respective definitions assigned to such terms in the Agreement.

IN WITNESS WHEREOF, the parties have caused this Amendment to be signed by their duly authorized representatives as of the date and year first written above.

CODEXIS INC.	MERCK SHARP and DOHME Corp.
By:__________________________	By:__________________________
Name: John J. Nicols	Name: Stephen Bariexca
Title: President and CEO	Title: Sourcing Analyst
Date: February 25, 2015	Date: March 10, 2015

-1-